PULMONARY TUMOUR THROMBOTIC MICROANGIOPATHY

PULMONARY TUMOUR THROMBOTIC MICROANGIOPATHY was reported 77 times

These drug classes are most commonly taken by patients reporting PULMONARY TUMOUR THROMBOTIC MICROANGIOPATHY:

# Drug Count
0 Microtubule Inhibitor [EPC] 18
1 Kinase Inhibitor [EPC] 14
2 Platinum-based Drug [EPC] 13
3 Nucleoside Metabolic Inhibitor [EPC] 11
4 Vascular Endothelial Growth Factor Inhibitor [EPC] 10
5 Phosphodiesterase 5 Inhibitor [EPC] 9
6 Aromatase Inhibitor [EPC] 8
7 Estrogen Receptor Antagonist [EPC] 8
8 RANK Ligand Inhibitor [EPC] 8
9 mTOR Inhibitor Immunosuppressant [EPC] 8
10 Endothelin Receptor Antagonist [EPC] 7
11 Programmed Death Receptor-1 Blocking Antibody [EPC] 7
12 Corticosteroid [EPC] 6
13 Vasodilator [EPC] 6
14 Alkylating Drug [EPC] 5
15 Folate Analog Metabolic Inhibitor [EPC] 5
16 Calcium Channel Blocker [EPC] 4
17 Dihydropyridine Calcium Channel Blocker [EPC] 4
18 Programmed Death Ligand-1 Blocker [EPC] 4
19 Angiotensin 2 Receptor Blocker [EPC] 3
20 Insulin Analog [EPC] 3
21 Loop Diuretic [EPC] 3
22 Prostacycline Vasodilator [EPC] 3
23 Sulfonylurea [EPC] 3
24 alpha-Glucosidase Inhibitor [EPC] 3
25 Catecholamine [EPC] 2
26 Epidermal Growth Factor Receptor Antagonist [EPC] 2
27 Factor Xa Inhibitor [EPC] 2
28 HER2/neu Receptor Antagonist [EPC] 2
29 Penem Antibacterial [EPC] 2
30 Tumor Necrosis Factor Blocker [EPC] 2
31 Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] 2
32 Aldosterone Antagonist [EPC] 1
33 CTLA-4-directed Blocking Antibody [EPC] 1
34 Fluoroquinolone Antibacterial [EPC] 1
35 Human Immunoglobulin G [EPC] 1
36 Methylxanthine [EPC] 1
37 P2Y12 Platelet Inhibitor [EPC] 1
38 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1
39 Prostacyclin Receptor Agonist [EPC] 1
40 Prostacycline [EPC] 1
41 Proton Pump Inhibitor [EPC] 1
42 Soluble Guanylate Cyclase Stimulator [EPC] 1
43 Thiazide Diuretic [EPC] 1
44 Thrombopoietin Receptor Agonist [EPC] 1
45 Topoisomerase Inhibitor [EPC] 1